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Effect of single dose magnesium on arrhythmias in patients undergoing coronary 
artery bypass surgery 
Mohammad !Iamid 1, Rchamt Sha II Kamal·\ Slw.hid Ahmed Sami\ Farouk A tiq 1, A:t:am Shaf'-1ua1>, ll~unid lq!l :\'<h]Yi(', 
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Abstract 
Objective: To evaluate the safety cmd role of prophylactic administration of magnDsium m preventing 
arrhythmias. 
Method: This double: blind randomi;ed placebo controlled clinical trial was conducted at J-\~F~ Khc_m University 
Hospital on coronCJry artery bypass surgery patients. All patients were connected to holter monitor before 
induction of anaesthesia and this monitoring continued for 24 hours. Study drug containing either ?-9rams of 
magnesium or normal saline was given 8fter intubation. Levels of serum magnesium was chcckDd prooperatively 
and then in ICU at 0, 6, 12, and 24 hours. Independent t-test and chi square test wero usod for analysis. 
Statistical signif,cance was de~ fined as p-valuc < 0.05. 
Results: A total of 104 patients consented to participate in the study, 53 patients wnrc randomly allocated in 
magnesium (Mg) group and 51 ·m placebo group. Two (3.77%) pationts in magnesium nroup ~md five patinnts 
(9.8%) in placebo group developed atrial fibrillation. Incidence! of ventricular and supraventricular tachycardic:J 
was also slightly higher in placebo. Mg level after arrival in CICU (Cardiac Intensive Care; Unit) showed rnnan oi 
2.1 in magnesium group and 1.6 in placebo group (p::: 0.6). 
Conclusion: Low magnesium levels were noticed in the placebo group after cardiopulrnon~Jry bypass and 
although prophylactic administration of magnesium sulphate was relatively safe but sinnificdnt bcndit on 
prevention of arrhythmias could not be attained (JPMA 5B:22;200B). 
Introduction 
Arrhythmias an_> not uncotlllll(lll after comnary 
Ulicr.Y bypass surgery (C/\B(;)_ The reported incidence nr 
supra ventriculZJr arrhythrni:t ran~cs from 40-4TYol, whncas 
ventricular arrhythmia.s !s :~.-:J-(>;,_r There arc reports 
suggesting that mag.ncsiun1 reduces 1hc incidence of 
ventriculur arrhythmia] a11d supra\·c:n1riculur arrhythmius 
including atrial llbrilla.tion. 1.3 
Potc!llial complications ofpostopcratiYL' arrb:ythmia incl\ltk 
tllromhoc:mbnlic: events. hctcilwdynalllil· ctllnprtHnlsc_ 
increase length of s!.ay-1 and cost of hospitQiisation.' 
I-Jypomagne$acmia has bCL'll observed alter rardiuc 
surgery. and administrution of tn'1gncsi11m DJfcrs spcci<J] 
polcnti;_tl benefit to a patient undergoing C:'\IH..1. Poknli8l 
advantugc~ of magnesium include L'asy uvailahility. less 
cost, dccrcZJscd incidence und dmation of A. hh 'Jlld V 1', 
improved cardia.c index and rcduc:tioH iu infarct si/.c. ln 
human and animul models, rcpcr[usion injury due- to the 
release of cross clamp can be attcmwtcd by magnesium 
administration rc.sulting in tetter systolic indices or 
contractility. Furthermore a rcductiou in in!Jn;t si;:L' and 
mortality has hcen rcportcd. 7 
Atrial fihrilluhon (A. Fib). ntriaJ !ltti!LT. nml1dCJcal 
atrial tuchycurdia, supravL·ntricular 1achycardi;:t and non 
sustained ventricular tachycardi<.J (VI') are difkrcnt forms 
or arrbyt!Jmius hu( have the S£ltllC clinical implications in 
early JTcovTry phase of patients after cardmc surgery. 
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Dc.'lpitc all the advantages, routine administration of 
magnesium is still contrm·crsiol in cardiac surgery patient 
due to variable rcsltlts in previous ~tudlcsL-L:i and its 
potential compliratiuns. l'hc pt1111ose or this study was to 
establish the safety of prophylactic administration or 
magnesium and to observe the ~eduction in the incidence of 
post-operative arrhythmias iu p:1ticnts undl::rgoing coronary 
artery bypaS!-i surgery. 
Patients and Methods 
1 his double hhnd, ramlomised placcbn controlled 
clinical trial was undertaken after npproval from ethics 
review col1\\11itteL at Aga Khan University llospital 
Karachi. All patients U11dcrwcnt CABG ~urgery under 
genera 1 anaL'Sthcsia vvith the u.'\e of cardiopldmonary 
bypass. using a centrifugal pump, a membrane oxygenator 
and cold blood cardioplcgiJ for myocardial protection. One 
hnndrcd and ronr patients aged 35-?5 years \Vith normal 
renal runction and in normal sinus rhythm were included. 
E.xclu;,1on criteria \verc. patic11ts with acute or chronic renal 
Ltilmc. serum creatinine >2.0 mg/dL usc or intra aurtic 
bi..llloon pump. left ventricular ejection fraction -- J0°;(), 
cmcr~:t:tK"y snrgcry and patients on C-roup 1 and Ill anti 
arrhythmic drut:s. 
Parameters tnoniturcd included age. gender, bLCighL 
\vci~'hl. hypass tinw and cross clamp time. Preoperative 
card1~tc nsk E:tetors were also nokd including hypertension, 
diJhdcs nH.:llitus, prcviou~ !HJ'OC:J.rdi'Jl mfarctiL)Jl aml 
cerd1nwascular <:tt:cidcnt. 
Aller inl(mncd umscnt. patients vven: randumly 
~dlocatcd 10 one or the two study groups. Randomi:r.ation 
was donLC h) the hnspital ph<.nmacy, using computer 
~oftworc. Phanm1cy \\""d.'\ also rcspnnsihk for the preparation 
of 3 cc ,-;yringes cont<.ti.IJing either two grams or Magnc~ium 
stdphatc solution or normal saline. The syringes were 
lahcllcd with a co(k numher and the cnde qayed 111 the 
pharmacy dL'pJ11mcnt. llwesti~:ators were unaware of the 
contents of the syringes. 
Preopcrati\·cly pattents were !-()llm:vcd for llSLC or~~ 
Blockers and caleitun channel hlockers. presence ur 
arrhytlunias, history ot' lll_yocardi.:tl in!i:1rction and left 
\Tntricuhtr l~jection fmct1on. i\11 patiL'l1ts \\"ere prcmcdicakd 
with i.Dra/cpam :?n1g pn mal (PO)_ :.10 hour before shi!'ting 
to the operating room. All the pattcJllS wc:rc then cnnnectcd 
1o a bolter 1110n1tor (Pltilips /)illlild holtcr 20l01) !(Jr ECG 
monJtonng. Standard ntonitorinf1., inc1wling 5--lcad ECG 
\vas applied during surgery. A rtcr placement of intravenous 
and arterial line. patients were induced with midazolam. 
fentanyl and puncmonium bromide. Central line or 
pulmonary <Wtcry catheter was inserted and anaesthesia was 
maintained using 0.2 to 2% i~ollmanc in atr oxygen 
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mixturt'. 
Alter induction. 1..1H patients received tin: study drug. 
vv hich wa:,; added to I OOml normal saline and dClministercd 
intravenously ovt:-r a period of 30 miuute~. All patier~Js 
underwent C AHCi with blood cardioplegia for myocardi~1l 
protection after cross clamping. Body temperature was 
maintained at 28-301'C. PropoJ(ll infusion was started at the 
beginning of cardiopulmonary hypass and continued in the 
postoperative period 
Weaning from the pump vv·as started ltpon 
C(Jmpiction oj' byp~lSS SUrgery. cnmpktc fC\Varmmg to 
37.5°C' and scrurn potassium was kept hctwccn .-J_)-) 
mEq/1". AnaLsthesia \\as nlaiJttJ.iiJed durin.!:', post bypass 
period by using propofol 2mgikt;/hr. w·hilc vasodilator.., and 
I or ionotropcs inli1.siou was used for hacmodynamic 
stability. 
Ail postoperative palJCnts were ventilated WJtb 
synchronized intermittent mandotory vcntil<.Hion (SIM\') 
and pressure support, till extah~1tion. Serum magw:-;ium 
levels were monitnrrd prcopcr~tti\·cly, on shirti11g to ( '!Cl :, 
and later at(, hours, 12 hom::. an~l 7A hours postopcrati\·e\y_ 
1-loltcr monitnring was ClHltinucd in intraopc-r<HI\ c Jnd 
postoperative period for 24 hours and an< .. liyscd f()J" supn1 
ventricular tachycardia (SVT), utrictl fibrillation. lluttcr. 1run 
sustained VT and bradycardia lise of dcllhrillator and 
pacemaker was abo noted. 
At the til11l' or termination or tltl~ study. the (()Ck \Va~ 
broken and the pJtiL'Ht data \-vnc assembled mto placebo 
and magne:sium gruup!-i. 
Statistical procedures \vcrc done h)" using SPSS 1 .1.0 
software:. Values arc presented os mean-; ~tandanl de\ iatiun 
or percent or patients. Pruprtion were compared with ('hi 
square and Fisher's exact test Sll!dent'» t-tcst was u~cd for 
Qttantitativc variahlcs. L:nivariatc analysis W<-lS used f01 
correlation hctvn.T11 A. f'ib and other variable~. 
Results 
A total or 104 p~ttient.'i L'(H\Sentcd tn participate in tl1l' 
Sllldy, :<~ patients vVTIT nmdornly allocuted in mugncsillm 
group (Mg) and 51 \n piacchn group. 
Both groups were simiLJr it1 haseiiuc characteristics 
lllcluding age. gender. cjct:tion fraction. serum ckctm\ytcs 
a;-; wei! as usc of f.\ blockers. Preoperative magnesium levels 
\Yen: cnmparahlc in hoth groups. 
ThcrL' W~lS nu significant diifc.:rcncc in the previous 
hi~l\lry or lllyoca!dictl infarction. cross clamp tilllc Lllld 
cardiopttlt;1unar::l hypass time. There \Vas a statistically 
stgnif1eant ddTcrL'l1Cl' ill patient's magnesium levels. Mg 
group had<! lllL'~\J\ or 2.1 rntnpared to the pbceho group 1_2 
(p 'ctlnr <() 0'1 (labk l ). 
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l'able I. l'rco11t'ratiw patil'nt ch:lr<U'Icl·istics, lntraoperath·e detail.~ related to lHTh~·thmias and JIO~topct·ath·c serum l'lt'('tml)"k 1('\"Cis. 
("haractcristics 
:VIg woup Pl:u·cho group 
P- \'aim· 
:\lt·an sn 'V,, :\-1(-"an SD 'V., 
Age {Years) 
Weight (Kg) 
Male sex{%) 
Preop Left n:ntrlcular ejection fraction {''.t(,) 
Hearl Rate (per min.) 
Medication 
Myocardial infarctinn 
S.:rum Mg H· (mmoil.) *. 
lntr;t ti]Kl-ati, .. e lhctors 
CHI' umt· !tlltlll 
Cru~~ ci;Jtllp ::111c· (min) 
.\tier rcka.~~· of crnss clamp 
Dcfthrillatiutt 
Cardin~ersion 
Serum Mg+·l (mEq; L) in CICU at arrival 
Serum Mg++ {tllElj/1.) in CJCU at 6 hours 
Serum Mg+ · (tnEq/L) in ( 'ICU at 12 hours * .. 
Serum Mg ++ (mEq/L) in CICU at 24 hours, .. 
None 
B blocker 
None 
·,(l \vecks 
>(meeks 
Yes 
Yes 
58.3 }.() 
7(J.(l 12.~ 
53.3 11.1 
69.! 1:1.2 
8 15.1 
42 "192 
31 .""iX5 
4 7.) 
18 34.0 
2.0 O.J 
90.0 21).5 
5."U 17.() 
26 49.1 
5 9A 
2.1 (J..\ 
2.0 0.2 
2.1 0.2 
2.1 0.2 
5(d 
"/4A 
<>8 
50.-t 
68.4 
5 
II 
'(j 
I<• 
I.'J 
95.-~ 
_::;IJ.S 
2) 
.1 
].() 
2.0 
2.1 
2.n 
X.'J 
I J.J 
9.0 
lJ_l 
1).:) 
~0.4 
.'iX.X 
t).X 
11 1 
0.2 
)4.3 
IX.7 
4:.1.1 
5.1) 
(!.2 
0.3 
().}. 
0.2 
8(1 
0 .. ~ 
0.4 
0.0~ 
0.2 
(J."/ 
0.6 
(l.t) 
(J..'i 
0.3 
0.1 
u .. "o..t .. t 
0.716 
i)(J 
• Mi~sing \;oluc~ ;,, MG cnmp. Missing ~alu~s in pb(tbo ~~ouup. CI'IJ Cardiupuluwnary b: J"l'"> 
Table 2. lneilll'nec of oll-rhythmia in the int1·a and llOSlOpl't"aliH· pl'rinll- A univadal(· au:1lysis. 
Characteristic.~ 
!\1can 
_\lagncsium 
SVT after cross damp release ().()9 
SVT aftet· bypass in OR 0.02 
SVT inCICU I 17 
Atrial fibrillation after X clamp O.OCJ 
Atrial fibrillation after 13ypass in OR 000 
Atrial fibrillation in ClCL: 0.00 
VT after cross clamp release 1.04 
VT after Bypass in OR 0.4.5 
VT inCICU 0.5R 
Bradycardia I .2 I 
Supra ventricular ectopy 887.2 
Bradycardia 
Yes II 
No ·t1 
SVT Supr<~ vemricular tachycardia. VT Vcntticuklr ta<:hycardiu: X d:mltl" Crnss clamp relea.'c 
Incidence of ventricular tachycardia was comparable 
in the operating room in both groups but higher in Mg group 
in the CICU period. Mean episodes of VT were also higher 
in Mg group in the CICU (p-value 0.06). ('!able 2) 
24 
l'lill'C'hO 
I'-Value SD .\k;m SD 
0.40 U.JS 0.(12 0.-tJ 
0.14 0.02 0.14 0.98 
4.91 0.80 3.:>2 O.M 
(UO 0.12 o.'n 0.44 
0.00 0.02 0.14 0.32 
0.00 O.O(J 0.-12 (J.37. 
I.(J3 (J:i8 ()_l)LJ 0.34 
1.45 0.33 {)_1)1) 0.59 
1.5CJ 0.14 O . .i3 0.06 
OAI 1.12 0 .. \2 0.2.7. 
4R!:\.5 352.8 l:lJS.X O..t5 
20.75";() 06 l I ."16'}!. 
7lJ.24'}(, 45 8H.2Y~·;, 0.21 
Eleven (20.75%) patients in the magnesium group 
were diagnosed with bradycardia in the first 24 hours after 
bypass while in placebo group only 6 (I L76'Y,) patients 
developed bradycardia (p -0.22)(Table 2). Pacemaker 
J Pak Med Assoc 
A. Fib SVT VT 
requirement \\'as also slightly higher in magnesium group (4 
vs 3 patients). 
Seven patients developed A. Fib in both the groups. 
Out of these 4 were kmalc and 3 were males. A. Fib 
developed soon after cross damp release in 5 patients while 
one patient developed A. Fih in CJCU and one in the OR 
after bypass period Mean age of the patients who 
developed A. Fib vva~-; 5S t 10.34 years. 
Only two (3.7T%) patients in the magnesium group 
acquire new onset A. Fib in the first 24 homs (Figure l). 
Both of these patients developed A. Fib soon after the 
rclea~c of cross clamp and their Mg levels remained within 
normal limit during the study period. Five patients (9.W%) in 
placebo gronp dt:vcloped A. hb with the mean Mg levels of 
1.42 mgidl on arrival in CIClJ. 
Discussion 
Magnesium plays an important role m 
cardiovascular physiology. It is an essential en~ factor Hl 
maintaining the intracellular electrolyte balance and 
membrane potential by acting on Ka-K:-Al'P channels. It 
also acts like a natural calcium antagonist and its dcficicnc_y 
decreases the threshold for arrhy·thmia.·' 
BypomJgneS<ll'tni:J i." commonly ohscrvcd artcr 
cardiac surgery \'>hich nwy be related to hacmodi\ution. 
intra operative and postoperative cellular dcp!etion, intru 
operative diuretic use:, secondary hyper aldosteronism, high 
levels of epinephrine_ increased anabolic activity. extreme 
stress and increased uri1wry loss. MgS04 reaches its 
minimum level on first po~top day (FOD) and returns to its 
prcop value on 4th POD.t) In this study, ~-;ignificuntly lov\ 
Mg levels in the placebo groups after ( 'ABG \Vcre also 
noticed. These low lcvch of Mg are con$idcn::d to be 
responsible for arrhythmias seen after C'ABG. 
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Atrial fibrillatiOn is the most commonly observed 
arrhythmia after cardiac surgery, which might lead to 
hacmodynamic disorders. thromboembolism and increased 
ICU and hospital stay. Exact cause for A. fib is unknown but 
aortic cross clamping and intlammatory response during 
bypass is considered to be a factor in the dcn:lopmcnt of A. 
Fib. Contrary to this, recent articles mentioned the same 
incidence of A. Fib in off pump C ABG.'I Most impmiant 
contributing !actor is considered to be the age of the patient 
due to age related structural changes in the atriums_ which is 
hue in the prcscnt study as vvcll. Atrial ischaemia due to 
possible kinking of grafts or poor myocnrdial protection and 
rapid re-warming might be other reasons. 
Scvcr<d prophylactic strategies have been used for A. 
Fib vvhich includes usc of magnesium as a single dose, 
continuous !\1g infusion for several days, use of~ b!ockcr~'J, 
amiodaroncl 0 and dil1iazem 11 , but all these drug!> have 
limited success. A meta analysis by Shiga et al. concluded 
that prophylactic magncsium reduces the incidence or AF 
after CABG about 23%,. P Use of prophylactic and 
continuous infusion is being used in sever"Jl centres. llsing 
magnesium grcatt::r thun 4 grams has been associatL·d \vith 
occurrence of hradycardia 1-' requiring pacing for 24 hours 
and mild hypotension V·/hich is responsive to fluid 
administration. 
In the present study, we gave single infusmn of 2 
gram of magnesium only in Mg group. ln the postoperative 
period, Mg levels were kcpt normal in both groups hy 
regular cheL·king of Mg level and bolnscs accordingly. The 
incidence or atrial fibrillation in this study treatment and 
placebo group did not reach statistical significance while 
other studies have shown higher incidence. The reason 
might be that these patients were monitored for only 24 
hours while in other studies monitoring was continued for 
four days or more. Stephan ct a! have monitored these 
patients for live days and noticed highest incidence of atrial 
fibrillation on 1st postop day 1·1 and signiflcant benefit or Mg 
was abo noticed on first postop day. Mchmet et al in their 
study mentioned that more than 7.5% of patients develop!\. 
J<'ih on 2nd postop day.·l Another rcuson for lown incidence 
in the cmrent study may be that magnc~imu was replaced in 
both groups by snppkmcntation in CiCU tn keep the serum 
levels \Vithin normal limits. 
A review of literature sbm,..:ed different dosages <.Jnd 
duration or Mg in each study. In some studies infusion v..:<JS 
continued f()r 3 days 1) whilL; in others Mg level \\·as checked 
regularly and supplemental Mg \Vas given in case of 
hypomagncsacrnia. In the present study, higher \.1g len.< is 
a5:->ociated with higher incidence of mrial fibrillatJOJLH' In 
our sntdy none of the patients show~._·d higher !Vlg level. 
which exceeds physiological range. 
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Several studies have shown that serum Mg level 
whether total or ionized, is not a rehahlc indicator of total 
body stores ofMg. 14 Low myocardial Mg content may be an 
indicator of arrhythmia. The value of semm Mg remains 
questionable and further studies arc needed to shO\v the 
relevance of serum Mg and mThythmia. 
Most of the studies evaluated relationship between 
Mg and atrial fibrillation in CJ\BG patients but the role of 
Mg in other an·hythmias like VT and sinus bradycardia has 
to be evaluated. Hans eta! noticed the same incidence ofVT 
in both Mg and non Mg groups.s Stephen ct al found a 
higher incidence of VT in cm1trol group on 5th POD.l 4 
Interestingly the current study hnmd that VT was higher in 
Mg group in the CICU, although Mg levels were kept 
nonnal. The overall incidence of postoperative arrhythmias 
with tv1g supplementation did not reach statistical 
significance. 
The limitations of this study were a small number of 
patients, and previous history of atrial fibrillation \Vas not 
considered in this study. 
Timing of prophylactic Mg might bt.:: important. In 
the present study, Mg was given after induction and before 
bypass surge1y. In the previous studies prophylactic Mg 
infusion was given in the postop period despite of nonnal 
Mg levels and V./aS associated with lower incidence of atrial 
fibrillation (whether levels were normal or lm~').l"! 
England et al notlccd decreased incidence of 
ventricular arrhythmias when 2 gm prophylactic Mg was 
gl\ren intraoperatively v.,rhile it had no effect on 
supraventricular arrhytlunias. 1 In the present study, Mg 
group had higher incidence of ventricular arrhythmias and 
bradycardia, while supraventricular arrhythmias were low. 
Most of the ventricular arrhythmias occurred after release of 
cross clamp, which was not considered in England study 
and they included only ICU patients. 
Some studies were done strictly after stopping f3-
blockers and Calcium channel blockers 17 or investigators 
chose those patients who were not on these drugs, while in 
other studies these drugs were continued. lt has been seen 
that combination of H- blockers wlth Mg has no additive 
effect than their use alone. lt is also revealed that incidence 
of postop A. Fib is increased in patients in whom f3 -
blockers were withheld preoperatively, presumably due to 
enhanced action of catecholamine. The f3- blockers 
presumably prevent the loss of intracellulaf Mg.l:'l 
Conclusion 
The overall incidence of arrhythmia after CABG 
surgery with single dose magnesium supplement did not 
reach statistical significance as ln some of the other studies. 
Low magnesium sulphate levels were found in the placebo 
26 
group in this study as well, but a significant benefit for 
prevention of arrhythmia could not be attained with 
administratlon of magnesium sulphate. 
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Hand washing and gloving practices among anacsthctists 
Muecn Ullah Khan, Khalid Maudood Siddiqui 
1 )eparhncnt or 1\ naesthc.'.ia and illlt:Jl~ive Care, /\ga Khan l !ni vcr:;1 \y, Karachi 
Abstract 
Objective: To assess the complinance of anaesthetists towards gloving on shifting the patients to post 
anaesthesia care unit and hand hygiene before leaving the PACU. 
Methods: The observational study was conducted in a tertiary care hospitaL An assigned nurse in the PACU was 
asked to observe the anaesthetists and mark on a proforma, the wearing of gloves during shifting a patient and 
later hand washing or using an alcohol rub before leaving the room. 
Results: A total of 496 observations were made. Overall compliance with woaring gloves during shifting of 
patients to PACU was 70% and practice of hand hygiene was observed in 62% of anaesthetists 
Conclusion: Implementation of hand hygiene policy and education has positive effects among anaesthetists. 
Compliance to the policy remained above fifty percent. In order to further improve the situation continuous 
education and definitive administration measures of hand hygiene practices are suggested (JPMA 58:27;2008). 
Introduction 
Practicing hand hygie-ne by health care \Vorkcrs i~ 
the single most important 11.1casurc to prevent cross 
transmission of microorganisms from one patient to 
another. 1 Compliancl' with Hlli\Trsal precautions. gloving 
standards and hand clransing remains inconsistent among 
health care workers especially in physicians_J. Transmission 
of microorganisms from the hand of health care v-,:orkers is 
the main source or cro~s infection and can be prcYented hy 
proper hand hygiene. No~ocomial infection i.e, a leading 
complication in critical arc.:Js. Hand hygiene represents the 
main way to prcYcnt and/ or reduce nosocomial in!Cction 
incidence. Anaesthctis1s take care of patients of different 
age groups, subspccialtics and co-morbidities. According to 
Our departmental infection CO!ltrC>\ policy, \\Taring o!' 
examination glove~ and n1aintcnancc of hand hygiene by 
anacsthcti~t;; is mandatory at the time of induction, 
maintenance of ainvay. intrclvcnous or arterial cannu\Jtion. 
handling of blood products, shifting or patient to post 
anaesthesia care unit (P.:\Cll) and in bct\vcen cases. Soiled 
glm--es shuuld be changed in between tbe procedures. 
Sl)ikd hands should he washed w~th pyodine scrub or 
othcnvisc using alcohol hand rub even after removal nf 
gloves. 
Initially hand hygiene at our institution consisted 
only uf!l<.lllli 'v\·ashing. Six mnntbs back .:1 baseline infection 
control Sllr\'CY regarding hand llygic-nc practices among 
Vol. 58, No. 1, January 2008 
he<~lth care '-'-Orkcn;, shovvc(\lo\:v compliance. Compliance 
among nurses n:maincd bet-ween 50-(>0%) while in doctors 
it was as low as J2%. Atlcr that a hospital-wide campaign 
to promote practice of universal precautions amLJng hcallh 
carc worker;; \vas launcllLd. Posters were display-'cd in 
strategic mea.<; throughout the institution conccrni'lg 
nosocomial inft:ction. cross transmission and impot1ancc of 
hand hygit:n<.: in general. Alcohol ba,scd hand rub solutions 
wen: made available in all operating rooms and PACLi. 
Alcohol based hand ruh solution (7:5'}-{J isopropyl alcohoL 
weight to weight ratio) contained 0.5°/c) chlorhcxidinc 
gluconatc and skin enwllicnts_ All opcrating room sta!lwas 
encouraged to rollow I land hygiene pohcy. 
During shifting of patients {l-om the operating room 
to PACU. maintenance oftbe airway is the responsihiiity of 
the anaesthclist. Since soilin~·- of hands from patient's oral 
secretions or von1itus c:.1n occur, there is a great r~sk of 
tr<:~nsmissinn or microorg,cmisms to the 8nacsthctist alld to 
the next raticnL /\nacsthdists arc expected to \veur glon~s 
during shif'ling or patients !'rom operating room to PACt· 
Soiled hands should he \vuslll'cl or alcohol ham\ ruh used 
after remm·al or glm-e;; and hcforc k<~Ying the PJ\Cl.i_ 
Three mnnlh.s after completion of campaign. we conducted 
an observational study to assess compliance wnb univc-r~al 
prec-autions mnong anclC.<;lhL'tJsts. regarding glov111g on 
shifting the patient to pus! an<:l<..'<ithcsia c.·arc unit and hand 
hygiene hdorc ka,·ing the PACl) 
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